Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001005201-20-000021
Filing Date
2020-03-10
Accepted
2020-03-10 08:16:51
Documents
125
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K asrt-12312019x10k.htm 10-K 2374113
2 EXHIBIT 4.5 exhibit45-descriptionofcom.htm EX-4.5 8401
3 EXHIBIT 21.1 exhibit211-subsidiaries.htm EX-21.1 6197
4 EXHIBIT 23.1 exhibit231-eyconsentfy2019.htm EX-23.1 4732
5 EXHIBIT 31.1 exhibit311-fy2019.htm EX-31.1 13018
6 EXHIBIT 31.2 exhibit312-fy2019.htm EX-31.2 12884
7 EXHIBIT 32.1 exhibit321-fy2019.htm EX-32.1 6842
8 EXHIBIT 32.2 exhibit322-fy2019.htm EX-32.2 6922
15 chart-830df74bae0d644107fa20.jpg GRAPHIC 38425
  Complete submission text file 0001005201-20-000021.txt   13714726

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT asrt-20191231.xml EX-101.INS 2946563
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20191231.xsd EX-101.SCH 97552
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20191231_cal.xml EX-101.CAL 135425
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20191231_def.xml EX-101.DEF 632875
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20191231_lab.xml EX-101.LAB 1258110
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20191231_pre.xml EX-101.PRE 848451
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

EIN.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13111 | Film No.: 20699959
SIC: 2834 Pharmaceutical Preparations